Latest News

TAAT: Releases Video Advertisements as Part of Ohio Launch Campaign; CEO Setti Coscarella Appointed to Taat’s Board of Directors

To augment current digital marketing initiatives, the Company has produced a series of video advertisements which are to be shown to potential users of Taat in the United States, who are current tobacco smokers of legal age. Between short-form brand advertisements as well as a 45-second segment featuring the Company’s CEO Setti Coscarella briefly narrating Taat’s approach to capturing market share in the tobacco industry, the Company believes these advertisements could improve brand recall and conversion rates for promotional campaigns. Additionally, Mr. Coscarella has officially been appointed to the Company’s board of directors.

ALTRIA: Announces Conversion of Its Non-Voting Shares in JUUL; Does Not Intend to Exercise Governance Rights Pending FTC Litigation Outcome

Altria Group, Inc. (Altria) (NYSE:MO) announces today that it has elected to convert its non-voting shares in JUUL Labs, Inc. to voting shares, pursuant to its December 2018 investment in JUUL.

20NE LABS INC.: 2ONE™ 100% tobacco-free nicotine white portion pouch hits USA modern oral nicotine (MON) market

2ONE™ (Twenty One) the first and only 100% tobacco-free nicotine white portion pouch made with TFN® non-tobacco nicotine, is now available in the USA from 20NE Labs Inc..

ACHIEVE: Announces Patent Granted in the U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, announced that the United States Patent and Trademark Office has granted Achieve a patent (US 2020/0172544 A1) on novel analogs of cytisinicline, a process for their preparation, and their use in the prevention or treatment of CNS and addictive disorders.

DUKE-UNC TOBACCO TREATMENT SPECIALIST TRAINING PROGRAM: Goes Nationwide with the Launch of Interactive Online Training

Expansion of leading Southeast US smoking cessation training program into virtual training makes its evidence-based curriculum available to healthcare and public health professionals everywhere

TAAT HERB CO.: To Launch Hemp Cigarette as a Novel Alternative to Big Tobacco Products

Taat Herb Co., flagship brand of Taat Lifestyles & Wellness Ltd., is preparing to launch its Taat brand of hemp cigarettes, a tobacco alternative that uniquely replicates the experience of smoking a traditional cigarette.

CANADIAN VAPING ASSOCIATION: Banning flavours increases tobacco consumption

The Canadian Vaping Association (CVA) has continually attributed flavours to the high success rate of vaping, while cautioning government and health officials that banning flavours would cause an increase in smoking rates and black-market sales.

THE FOUNDATION FOR A SMOKE-FREE WORLD: COVID-19 Social Distancing and Stay-at-Home Policies Lead to Increased Dependence on Tobacco as Stress Coping Tool

Survey finds pandemic is taking toll on mental and physical health of smokers, and millions around the world are responding with increased smoking

TECHNAVIO: Analysis on Impact of COVID-19-Nicotine Gum Market 2019-2023 | Awareness About the Harmful Effects of Cigarette Smoking to Boost Growth | Technavio

Technavio has been monitoring the nicotine gum market and it is poised to grow by USD 522 million during 2019-2023, progressing at a CAGR of over 5% during the forecast period. The

FOUNDATION FOR A SMOKE-FREE WORLD: Confusion about Quitting Options Impacts the Health of 1 Billion Smokers Globally

New Global Poll of Current and Former Tobacco Smokers and Harm Reduction Product Users Finds Broad Misperception of Nicotine as Potential Carcinogen, Expanding Gaps in Quit Attempts Across Countries

SNOWPLUS: All New SNOWPLUS Pro Puts the Evolution of Vaping in Your Hands

SNOWPLUS Pro packs the peaks of vapor technology into one sleek, premium package

U.S. FDA: FDA permits sale of two new reduced nicotine cigarettes through premarket tobacco product application pathway

The U.S. Food and Drug Administration announced it has authorized the marketing of two new tobacco products manufactured by 22nd Century Group Inc. – Moonlight and Moonlight Menthol, which are combusted, filtered cigarettes that contain a reduced amount of nicotine compared to typical commercial cigarettes.

Tobacco News Wire